23:35:31 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



Bee Vectoring Technologies International Inc
Symbol BEE
Shares Issued 138,012,601
Close 2023-05-01 C$ 0.065
Market Cap C$ 8,970,819
Recent Sedar Documents

Bee Vectoring arranges $270,000 private placement

2023-05-02 12:00 ET - News Release

Mr. Ashish Malik reports

BEE VECTORING TECHNOLOGIES PROVIDES CORPORATE UPDATE

Bee Vectoring Technologies International Inc. has arranged a non-brokered private placement of 2.25 million units issued at a price of 12 cents per unit for gross aggregate proceeds of $270,000. Each Unit is comprised of one common share (each a "Share") and one common share purchase warrant (each a "Warrant"). Each Warrant is exercisable to acquire one additional Share of the Company for a period of 36 months from closing at a price of $0.20.

No finder's fees will be payable in connection with the Private Placement. The Company intends to use the gross proceeds from the Private Placement to fund its ongoing growth strategy in the agricultural space, for continued research and development, marketing services and general working capital purposes.

All securities issued pursuant to the Private Placement will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable securities laws of Canada.

The Company also announces that it will be issuing 771,014 Shares at a price of $0.08625 per Share (the "Settlement Shares"), to settle a semi-annual interest payment due to Sorbie Bornholm LP pursuant to the issuance of 1,900 notes for gross proceeds of $1,900,000 from the private placement that closed on July 11, 2022 (the "Sorbie Private Placement").

Pursuant to applicable Canadian securities laws, the Settlement Shares issued pursuant to the Sorbie Private Placement will be issued under prospectus exemptions and are not subject to any hold periods or resale restrictions.

Closing of the proposed Private Placement and issuance of the Settlement Shares is anticipated to occur on or about May 9, 2023.

The Company also announces that it has granted an aggregate of 500,000 stock options (the "Options") to a consultant of the Issuer at a price of $0.085 per share for a period of five years from grant, pursuant to the Company's Stock Option Plan. The Options will vest immediately. In addition, the Company has issued an aggregate of 5,278,125 restricted share units (the "RSUs") have been granted to directors, officers, consultants and contractors pursuant to the Company's shareholder approved restricted share unit plan (the "RSU Plan"). 50% of the RSUs will vest immediately with the remaining 50% vesting three months from the date of issuance. Each RSU shall entitle the holder thereof to acquire one Share of the Company by delivering a notice of acquisition to the Company in accordance with the RSU Plan. In accordance with the RSU Plan, the RSUs were priced at $0.10 which was above the market close on May 1, 2023. The RSUs were awarded to certain directors, officers, consultants and contractors who have agreed to restructure their compensation and receive RSUs in lieu of certain cash payments for past and future services.

The Stock Options and RSUs are subject to a statutory four month and one day hold period that will expire on September 3, 2023.

About Bee Vectoring Technologies International Inc.

BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides - and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide and has US EPA registration of its Vectorite(TM) with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops. Additional information can be viewed at the Company's website www.beevt.com. To receive regular news updates from the Company, subscribe at www.beevt.com/newsletter.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.